GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbo... GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection. 詳細を表示
Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024 PR Newswire WALTHAM, Mass., Nov. 12, 2024 Company to highlight lead program CR-001, a tetravalent VEGF1 x PD-1...
GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that data from multiple clinical trials studying uproleselan in patients with acute myeloid leukemia (AML) have been accepted for presentation...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0017 | 0.707449022056 | 0.2403 | 0.2485 | 0.1912 | 725239 | 0.22073102 | CS |
4 | -0.048101 | -16.5807770397 | 0.290101 | 0.3662 | 0.1912 | 754656 | 0.27812681 | CS |
12 | 0.073 | 43.1952662722 | 0.169 | 0.63 | 0.1406 | 21140329 | 0.47683246 | CS |
26 | -0.018 | -6.92307692308 | 0.26 | 0.63 | 0.1406 | 11565264 | 0.44708801 | CS |
52 | -2.318 | -90.546875 | 2.56 | 3.5299 | 0.1406 | 6423065 | 0.49557001 | CS |
156 | -1.348 | -84.7798742138 | 1.59 | 4.16 | 0.1406 | 2393296 | 0.64589652 | CS |
260 | -5.278 | -95.615942029 | 5.52 | 6.09 | 0.1406 | 1651734 | 0.97558046 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約